VOLUME 32: NO. 11 NOVEMBER 2005
Editorials
Adding Nails to the Coffin of Underpowered Trials

S.D. Halpern.........2065
Discovering That B Cells Are Important in Rheumatoid Arthritis

R.J. Looney.........2067
Can MRI of the Knee Predict Future Malalignment?

K.A. Syed, N.N. Mahomed .........2070
Bones, Blood Vessels, and the Immune System:
What's the Link?

R.S.M. Yeung .........2072
Predictive Value of ANCA in Small-Vessel Vasculitis:
Is the Glass Half Full or Half Empty?

C.A. Stegeman.........2075
Treatment of Hepatitis C Virus-Related Systemic Vasculitis

P. Cacoub, D. Saadoun, D. Sene,
N. Limal, J-C. Piette .........2078
Articles
The Prevalence of Underpowered Randomized
Clinical Trials in Rheumatology

H.I. Keen, K. Pile, C.L. Hill .........2083
The Predictive Value of RF Isotypes, Anti-CCP Antibodies, and ANCA for Mortality in Patients with RA

S. Sihvonen, M. Korpela, A. Mustila, J. Mustonen.........2089
Effects of ACE Inhibition and Statin Treatment on Inflammatory Markers and Endothelial Functions in Patients with Longterm RA

C. Tikiz, O. Utuk, T. Pirildar, et al .........2095
Modification of Pro- and Antiinflammatory Cytokines and Vascular-Related Molecules by TNF-a Blockade in Patients with RA

I. Macías, S. García-Pérez,
M. Ruiz-Tudela, F. Medina, N. Chozas,
J.A. Girón-González .........2102
Safety and Efficacy of Rituximab in Patients with RA Refractory to DMARD and Anti-TNF-a Treatment

J. Higashida, T. Wun, S. Schmidt, S.M. Naguwa,
J.M. Tuscano.........2109
Anti-TNF-a Therapy Augments DPP IV Activity and Decreases Autoantibodies to GRP78/BIP and PGI in Patients with RA

J.C. Mavropoulos, M. Cuchacovich,
C. Llanos, et al.........2116
Staphylococcus aureus in Patients with RA Under Conventional and Anti-TNF-a Treatment

S. Bassetti, S. Wasmer, P. Hasler, et al.........2125
Skin Cancer, RA, and TNF Inhibitors

E.F. Chakravarty, K. Michaud, F. Wolfe .........2130
Static Wrist Splint Use in the Performance of Daily Activities by Individuals with RA

A. Pagnotta, N. Korner-Bitensky, B. Mazer,
M. Baron, S. Wood-Dauphinee.........2136
The Clinical Spectrum of ANA Associated with the Nuclear Dense Fine Speckled Immunofluorescence Pattern

A. Dellavance, V.S.T. Viana, E.P. Leon,
E.S.D.O. Bonfa, L.E.C. Andrade, P.G. Leser.........2144
SLE in a Multiethnic Cohort (LUMINA): XXIX.
Elevation of ESR Is Associated with Disease
Activity and Damage Accrual

L.M. Vilá, G.S. Alarcón, G. McGwin Jr,
H.M. Bastian, B.J. Fessler, J.D. Reveille,
for the LUMINA Study Group.........2150
Enhanced Expression of Programmed Death-1
(PD-1) / PD-L1 in Salivary Glands of Patients with SS

M. Kobayashi, S. Kawano, S. Hatachi, et al .........2156
Serum Relaxin in SSc

N. Giordano, P. Papakostas,
B. Lucani, et al.........2164
Predictive Value of ANCA in Small-Vessel Vasculitis

F. Lurati-Ruiz, F. Spertini.........2167
IL-6 Promoter Polymorphism at Position -174 in GCA

C. Salvarani, B. Casali, E. Farnetti, et al.........2173
Association of a Functional INOS Promoter
Variant with Susceptibility to Biopsy-Proven GCA

M.A. Gonzalez-Gay, J. Oliver, E. Sanchez, et al.........2178
Infliximab to Etanercept Switch in Patients with SpA and PsA: Preliminary Data

C. Delaunay, V. Farrenq, A. Marini-Portugal,
J-D. Cohen, X. Chevalier, P. Claudepierre.........2183
Female Gout: Clinical and Laboratory Features

A.W.S. de Souza, V. Fernandes, A.J.L. Ferrari.........2186
Prevalence and Risk Factors for Urolithiasis in
Primary Gout: Is a Reappraisal Needed?

J. Alvarez-Nemegyei, M. Medina-Escobedo,
S. Villanueva-Jorge, J. Vazquez-Mellado.........2189
Structural Factors Associated with Malalignment in Knee Osteoarthritis: The Boston Osteoarthritis Knee Study

D.J. Hunter, Y. Zhang, J. Niu, et al .........2192
Relationship Between Bone Markers and Knee Cartilage Volume in Healthy Men

Y. Wang, P.R. Ebeling, F. Hanna, R. O'Sullivan,
F.M. Cicuttini.........2200
Increased MCP-1 in Knee Joints of Rats with AIA:
In Vivo Microdialysis

S-H. Liu, C-S. Wong, D-M. Chang .........2205
Risk of Hospitalization with Peptic Ulcer Disease or GI Hemorrhage Associated with Nabumetone, Arthrotec®, Diclofenac, and Naproxen in a Population Based Cohort Study

N.L. Ashworth, P.M. Peloso,
N. Muhajarine, M. Stang.........2212
Patterns of Use and Public Perception of OTC Pain Relievers: Focus on NSAID

C.M. Wilcox, B. Cryer, G. Triadafilopoulos .........2218
Pediatric Rheumatology
Primary SS in Children and Adolescents:
Are Proposed Diagnostic Criteria Applicable?

K. Houghton, P. Malleson, D. Cabral, R. Petty,
L. Tucker.........2225
OPG Serum Levels in Kawasaki Disease:
An Additonal Potential Marker in Predicting Children with Coronary Artery Involvement

G. Simonini, L. Masi, T. Giani, et al.........2233
MRI in Pachydermodactyly

A. Anandacoomarasamy,
H-S. Bak, A. Peduto, N. Manolios.........2239
Case Report
Lymphomatoid Granulomatosis: A Rare Mimicker of Vasculitis

S.M. Wu, Y. Min, N. Ostrzega, P.J. Clements,
A.L. Wong.........2242
OMERACT 7
International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials,
Asilomar, California, USA, May 8-12, 2004
Progress Since OMERACT 6 on Including Patient Perspective in RA Outcome Assessment

J.R. Kirwan, M. Ahlmén, M. de Wit, et al.........2246
Incorporating the Patient Perspective into Outcome Assessment in RA Progress at OMERACT 7

J.R. Kirwan, S.E. Hewlett, T. Heiberg, et al .........2250
Attributes and Skills of an Effective Musculoskeletal Consumer

P.S. Tugwell, A.J. Wilson, P.M. Brooks, et al .........2257
Outcome Measures in PsA

D.D. Gladman, P.J. Mease, G. Krueger, et al.........2262
Fibromyalgia Syndrome

P.J. Mease, D.J. Clauw, L.M. Arnold, et al .........2270
Correspondence
The Arthritis of Familial Mediterranean Fever
I. Uthman.........2278
The Arthritis of Familial Mediterranean Fever: Reply
M. Lidar, A. Livneh.........2278
Letter
Can Hand Assessments Designed for Persons with Scleroderma Be Valid for Persons with RA?
J.L. Poole, K.J. Cordova.........2278
Corrections
J Rheumatol 2005; volume 32: number 8.
Table of contents.........2280
Ibuprofen May Abrogate the Benefits of Aspirin When Used for Secondary Prevention of Myocardial Infarction
M. Hudson, M. Baron, E. Rahme, L. Pilote.........2280
Meetings in Rheumatology